Merck defeats earnings expectations, brings up purchases expectation on sturdy need for leading medicines like Keytruda - CNBC

.Merck beats earnings desires, rears sales overview on solid need for top medications like Keytruda CNBCMerck &amp Co. (MRK US) Trumps Income Forecasts as Keytruda Sales Increase BloombergMerck Stock: Pharma Giant Posts Powerful Results, However Expectation Falls Short Real estate investor's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps income and also sales assumptions among Keytruda strength, yet provides mixed full-year expectation MarketWatch.